查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2094169

核子醫學掃描術診斷設備市場－2026-2032年全球市場預測

Nuclear Imaging Equipment Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，核子醫學掃描術診斷設備市場規模將達到 95.5 億美元，複合年成長率為 6.14%。

主要市場統計數據
基準年 2025 62.9億美元
預計年份：2026年 66.6億美元
預測年份 2032 95.5億美元
複合年成長率 (%) 6.14%

執行摘要：核子醫學掃描術診斷在精準診斷的應用

核子醫學掃描術診斷系統是精準診斷的核心，它不僅能幫助臨床醫師觀察解剖結構，還能展現生理過程。單光子發射電腦斷層掃描（SPECT）、正子斷層掃描（PET）、PET/CT混合影像、SPECT/CT和PET/MRI等影像方式，在腫瘤學、循環系統、神經病學、內分泌學、感染疾病影像和治療診斷學等領域有著廣泛的應用。癌症、心血管疾病和神經退化性疾病日益加重的臨床負擔，以及放射性追蹤劑的廣泛應用（這些示蹤劑能夠改善疾病的檢測、分期、治療選擇和治療進展監測），都推動了核子醫學影像系統的發展。此外，醫院現代化改造、放射性藥物分發網路的擴展、輻射安全監管要求以及分子成像在個人化醫療中日益重要的作用，也對該領域產生了影響。隨著醫療保健系統優先考慮早期診斷和循證護理路徑，核子醫學掃描術診斷系統不僅因其影像品質而日益受到重視，而且因其工作流程效率、劑量最佳化、運轉率、互通性和生命週期成本效益而受到重視。

核子醫學掃描術診斷設備領域的變革性變化

核子醫學掃描術診斷設備市場正經歷結構性轉型，從獨立的診斷系統轉向利用軟體的整合分子影像平台。混合成像將代謝和功能數據與解剖定位資訊結合，是臨床決策的核心，能夠提高複雜疾病路徑中診斷的可靠性。設備設計正圍繞數位檢測器、飛行時間斷層掃描（TOF-PET）功能、先進的重建演算法、運動補償、自動化品管和低劑量成像方案等。同時，醫療服務模式正從三級醫療轉向更廣泛的醫院網路和專業影像中心，這催生了對兼顧性能和操作便利性的擴充性系統的需求。治療診斷學的發展也是推動這一趨勢的重要因素，影像設備與標靶放射性藥物治療計畫、劑量測定和療效評估的結合日益緊密。供應鏈的韌性、同位素的可用性、訓練有素的人員、保險報銷政策以及對輻射防護標準的遵守情況，仍然是成熟和新興醫療系統採用這些設備的關鍵決定因素。

人工智慧在核子醫學掃描術診斷的累積影響。

人工智慧 (AI) 正累積成為核子醫學掃描術診斷設備整個價值鏈的驅動力，涵蓋從影像擷取和重建到影像診斷、工作流程最佳化和品質保證的各個環節。經臨床方案檢驗後，AI 驅動的重建可提高影像品質、降低雜訊、縮短擷取時間或減少放射性劑量。自動分割、病灶檢測輔助、量化工具和標準化匯總分析正在提高腫瘤科、循環系統和神經科工作流程的一致性。 AI 也透過輔助患者預約管理、最佳化掃描器利用率、選擇方案、動作偵測和預測性維護，提升營運效率。然而，AI 的應用需要透明的檢驗、法規核准、網路安全措施、臨床監督，以及與放射資訊系統、影像存檔系統、電子健康記錄和放射性藥物分發資料流的整合。預計 AI 將在能夠輔助核醫學專家的領域中發揮最大作用，例如減少重複性課責、提高可重複性，並在不影響安全性和診斷責任的前提下，支持可衡量的臨床生產力。

關於核子醫學掃描術診斷設備引進的關鍵區域性見解

在亞太地區，由於醫療基礎設施的投資、癌症治療能力的提升以及PET/CT和SPECT/CT技術的日益普及，分子影像的獲取正在迅速擴展和發展。中國、印度、日本、韓國和澳洲是主要的需求中心。在北美，核子醫學掃描術診斷領域擁有高度發展的生態系統，這得益於完善的保險報銷機制、與臨床指南的整合、放射性藥物的供應以及PET在腫瘤學、心臟影像和神經系統評估中的積極應用。在拉丁美洲，透過對公立和私立醫院的投資，分子影像的取得正在改善，但設備分佈不均、同位素物流、保險報銷制度的差異以及專科醫生的可及性等因素影響著各國的影像利用率。歐洲擁有成熟的核子醫學網路、統一的監管體系、合作臨床研究以及混合影像技術的積極應用等優勢，但設備採購取決於品質標準、輻射防護法規以及老舊診斷基礎設施的現代化改造。在中東，隨著三級醫療機構、國家癌症計畫和醫療城計畫的推進，先進的影像技術正在不斷擴展，尤其是在腫瘤學、循環系統和專科醫療計畫優先發展的地區。在非洲，核子醫學掃描術診斷已取得選擇性但顯著的進展，目前主要集中在主要都市區和學術機構。為了更廣泛地應用這些技術，人力資源開發、迴旋加速器和發生器的取得、服務支援、穩定的放射性追蹤劑供應以及永續的資金籌措模式至關重要。

影響核子醫學掃描術診斷設備需求的關鍵群體特定見解。

東南亞國協正透過醫院現代化、腫瘤服務拓展和跨境醫療投資來加強其核子醫學掃描術診斷能力，但其普及程度因收入水準、專家資源、保險報銷體系發展以及放射性示蹤劑供應基礎設施等因素而異。在海灣合作理事會（GCC）國家，先進影像技術被納入更廣泛的醫療轉型計劃，對三級醫療機構、癌症中心和重症患者監護路徑的投資正在推動PET/CT和SPECT/CT技術的應用。歐盟受益於協調的法規結構、跨境研究合作和既定的核子醫學標準，為品質保證、輻射安全和臨床整合創造了有利環境。在金磚國家，核子醫學影像技術的普及程度各不相同。中國和印度正透過醫療現代化和腫瘤領域的需求來提升其能力；巴西和南非繼續透過主要大都市地區擴大服務覆蓋範圍；俄羅斯則保持著受國內醫療優先事項影響的既有核子醫學能力。七國集團（G7）國家通常擁有成熟的設備基礎設施、先進的放射性藥物應用、完善的保險報銷流程，以及核子醫學掃描術診斷與腫瘤科、循環系統和神經科臨床流程的高度整合。北約成員國與歐洲和北美先進的醫療保健體系高度重合，在這些體系中，設備容錯性、安全的供應鏈、網路安全和可靠的醫院基礎設施對於診斷的連續性至關重要。

核子醫學掃描術診斷設備市場主要國家概況。

美國仍然是核子醫學掃描術診斷設備最先進的國家之一，這得益於PET和SPECT在腫瘤學、循環系統和神經病學領域的廣泛應用，以及成熟的放射性藥物製備、認證系統和臨床基礎設施。加拿大在公共醫療體系內強調品管的影像服務，其採購政策受省級規劃、醫療服務公平取得和設備升級需求的影響。在墨西哥，主要大都會圈和私立醫療中心的先進影像服務正在擴展，但其普及程度受到保險報銷、人員培訓和放射性示踪劑供應的影響。巴西擁有拉丁美洲最大的醫療保健系統，其主要醫院網路廣泛應用核子醫學掃描術診斷，但地理差異影響了主要大都市區以外地區的服務取得。在英國，核子醫學掃描術診斷透過基於指南的癌症、心臟病和神經系統疾病診療路徑得到支持，重點在於提升醫療能力、人員配備和設備水平。德國擁有強大的臨床和技術基礎，在混合成像、放射性藥物應用和醫院核醫方面實力雄厚。法國擁有完善的核子醫學服務體系，重點在於受監管的輻射防護、腫瘤影像和提供專科醫療服務。俄羅斯長期以來具備核醫學能力，並在國家醫療基礎設施發展優先事項的支持下，持續在腫瘤學和循環系統醫學領域應用SPECT和PET技術。義大利和西班牙的核子醫學掃描術診斷正在迅速發展。在印度，隨著癌症中心的建設和私營部門對診斷技術的投資，PET/CT和SPECT/CT的普及程度正在提高，但成本效益、同位素物流和人力資源開發仍然是重大挑戰。在日本，得益於完善的醫院網路和老齡化社會日益成長的醫療需求，影像診斷基礎設施十分發達，臨床應用已廣泛應用於腫瘤學、神經病學和循環系統等領域。在澳大利亞，各大城市均提供高品質的核醫學服務，其可及性取決於地區因素、專家分佈以及公私合營服務模式。在韓國，由於先進的醫院數位化、對癌症治療的需求、成熟的核醫學專業技術以及健全的三級醫療基礎設施，先進診斷技術的引進正在取得顯著進展。

為核子醫學掃描術診斷設備領導企業提供實用建議。

產業領導企業應優先考慮兼顧臨床性能和營運效率的儀器策略，包括更快的掃描方案、劑量治療診斷學、自動化品管和高系統正常運轉率。產品系列必須支援混合影像、診療整合工作流程、定量分析以及與醫院IT系統的無縫整合。銷售團隊應根據當地情況客製化產品和服務，包括資金籌措柔軟性、服務範圍、放射性追蹤劑取得途徑、培訓計畫和總體擁有成本 (TCO) 要求。與醫院、放射性藥物藥局、學術機構和監管相關人員夥伴關係，可以透過重新設計工作流程、員工培訓和合規準備來加速產品應用。此外，隨著買家在關注硬體效能的同時日益重視數位化功能，領導者應投資於人工智慧檢驗、網路安全、互通性和生命週期支援。在新興市場，永續成長取決於人才培養、服務可靠性、可操作的部署模式以及即使在基礎設施不完善的環境中也能正常運作的支援系統。

核子醫學掃描術診斷設備分析的調查方法

在對核子醫學掃描術診斷設備進行分析時，嚴謹的調查方法需要結合檢驗的醫療、監管、臨床和產業資訊來源的一手和二手資訊。二手研究應檢視同儕審查的核子醫學文獻、臨床指南、醫院採購趨勢、監管文件、報銷政策、放射性藥物供應考量、輻射安全標準以及關於癌症、心血管疾病和神經系統疾病的公共衛生數據。一手研究應包括對核子醫學專家、放射科醫師、心臟科醫師、腫瘤科醫師、醫院管理人員、循環系統藥劑師、醫學物理學家、採購經理和服務工程師進行結構化訪談。研究結果應從多個角度檢驗，包括臨床應用指標、已實施技術的趨勢、政策環境、工作流程要求、設備升級模式以及區域基礎設施狀況。調查方法應消除無根據的假設，避免依賴檢驗的說法，並強調資料檢驗、資訊來源可靠性以及跨區域和使用環境的一致性。

結論：核子醫學掃描術診斷設備是精準醫療的驅動力。

核子醫學掃描術診斷系統處於分子診斷、個人化醫療和數位化醫療服務三者的交會點。混合影像、人工智慧驅動的工作流程、治療診斷學應用、放射性示蹤劑的創新以及對高效、低劑量和可靠診斷路徑的需求，正在推動這一領域的變革。不同地區的部署情況差異很大，成熟的醫療系統專注於現代化和工作流程最佳化，而新興系統則優先考慮擴大服務覆蓋範圍、基礎設施建設和專家培訓。業界成功的關鍵在於提供經臨床檢驗的技術、可靠的服務生態系統、可互通的軟體以及高度靈活的經營模式。隨著醫療服務提供者對早期檢測、更精確的分期、更優的治療方案和更完善的治療監測提出更高的要求，核子醫學掃描術診斷系統將繼續在先進的診斷和治療決策中發揮至關重要的作用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章核子醫學掃描術診斷設備市場：依產品類型分類

  • 單光子發射電腦斷層掃描
  • 正子斷層掃描
  • 平面閃爍顯像系統
  • 核子醫學掃描術診斷。
  • 附件和輔助設備

第8章核子醫學掃描術診斷設備市場：依影像方式分類

  • 診斷性核子醫學影像
  • 治療性核子醫學影像

第9章核子醫學掃描術診斷設備市場：依技術分類

  • 模擬核子醫學掃描術診斷系統
  • 數位核子醫學掃描術診斷系統
  • 混合成像技術

第10章：核子醫學掃描術診斷設備市場：依檢測器類型分類

  • 閃爍檢測器
  • 半導體檢測器

第11章核子醫學掃描術診斷設備市場：按應用領域分類

  • 循環系統
  • 感染疾病診斷
  • 神經病學
  • 腫瘤學
  • 整形外科

第12章核子醫學掃描術診斷設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章核子醫學掃描術診斷設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章核子醫學掃描術診斷設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Absolute Imaging Inc.
  • Advanced Accelerator Applications SA by Norvatis
  • Agfa-Gevaert NV
  • Bayer AG
  • Bozlu Holding AS
  • Bracco Imaging SpA
  • Canon Medical Systems Corporation
  • CMR Naviscan Corporation
  • Cubresa Inc.
  • DDD-Diagnostic A/S
  • Digirad Corporation
  • Edge Medical Solutions Private Limited
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips NV
  • Mediso Ltd.
  • MR Solutions Ltd.
  • Neusoft Medical Systems Co., Ltd.
  • PerkinElmer Inc.
  • Revvity Inc
  • Rigaku Corporation
  • Shimadzu Corporation
  • Siemens AG
  • Surgiceye GmbH
  • United Imaging Healthcare Co., Ltd.
Product Code: MRR-50124643717F

The Nuclear Imaging Equipment Market is projected to grow by USD 9.55 billion at a CAGR of 6.14% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.29 billion
Estimated Year [2026] USD 6.66 billion
Forecast Year [2032] USD 9.55 billion
CAGR (%) 6.14%

Executive Summary: Nuclear Imaging Equipment in Precision Diagnostics

Nuclear imaging equipment is a core pillar of precision diagnostics, enabling clinicians to visualize physiological processes rather than anatomy alone. Modalities such as single-photon emission computed tomography (SPECT), positron emission tomography (PET), hybrid PET/CT, SPECT/CT, and PET/MRI support high-value applications across oncology, cardiology, neurology, endocrinology, infection imaging, and theranostics. Demand is being shaped by the rising clinical burden of cancer, cardiovascular disease, and neurodegenerative disorders, alongside wider adoption of radiotracers that improve disease detection, staging, therapy selection, and treatment monitoring. The sector is also influenced by hospital modernization programs, expanding radiopharmacy networks, regulatory requirements for radiation safety, and the growing role of molecular imaging in personalized medicine. As healthcare systems prioritize earlier diagnosis and evidence-based care pathways, nuclear imaging equipment is increasingly evaluated not only for image quality, but also for workflow efficiency, dose optimization, uptime, interoperability, and lifecycle cost performance.

Transformative Shifts in the Nuclear Imaging Equipment Landscape

The nuclear imaging equipment landscape is undergoing a structural shift from stand-alone diagnostic systems toward integrated, software-enabled molecular imaging platforms. Hybrid imaging has become central to clinical decision-making because it combines metabolic or functional data with anatomical localization, improving diagnostic confidence in complex disease pathways. Equipment design is evolving around digital detectors, time-of-flight PET capabilities, advanced reconstruction algorithms, motion correction, automated quality control, and lower-dose imaging protocols. At the same time, care delivery is shifting from tertiary academic centers toward broader hospital networks and specialized imaging centers, creating demand for scalable systems that balance performance with operational simplicity. The expansion of theranostics is another transformative force, as imaging equipment is increasingly linked with targeted radiopharmaceutical therapy planning, dosimetry, and response assessment. Supply chain resilience, isotope availability, trained workforce capacity, reimbursement policy, and compliance with radiation protection standards remain critical determinants of adoption across both advanced and emerging healthcare systems.

Cumulative Impact of Artificial Intelligence on Nuclear Imaging

Artificial intelligence is becoming a cumulative enabler across the nuclear imaging equipment value chain, from acquisition and reconstruction to interpretation, workflow orchestration, and quality assurance. AI-supported reconstruction can help improve image quality, reduce noise, and enable shorter acquisition times or lower administered activity when validated under clinical protocols. Automated segmentation, lesion detection support, quantification tools, and standardized uptake analytics are strengthening consistency in oncology, cardiology, and neurology workflows. AI also supports operational performance by assisting with patient scheduling, scanner utilization, protocol selection, motion detection, and predictive maintenance. However, implementation depends on transparent validation, regulatory clearance, cybersecurity safeguards, clinical oversight, and integration with radiology information systems, picture archiving systems, electronic health records, and radiopharmacy data streams. The strongest impact is expected where AI complements nuclear medicine specialists by reducing repetitive tasks, improving reproducibility, and supporting measurable clinical productivity without compromising safety or diagnostic accountability.

Key Regional Insights Across Nuclear Imaging Equipment Adoption

Asia-Pacific is advancing rapidly as healthcare infrastructure investment, expanding cancer care capacity, and rising adoption of PET/CT and SPECT/CT increase access to molecular imaging, with China, India, Japan, South Korea, and Australia serving as important demand centers. North America maintains a highly developed nuclear imaging ecosystem supported by established reimbursement pathways, clinical guideline integration, radiopharmaceutical availability, and strong use of PET in oncology, cardiac imaging, and neurological assessment. Latin America is improving access through public and private hospital investment, although uneven equipment distribution, isotope logistics, reimbursement variability, and specialist availability influence utilization across countries. Europe benefits from mature nuclear medicine networks, regulatory harmonization, clinical research collaboration, and strong use of hybrid imaging, while equipment procurement is shaped by quality standards, radiation protection rules, and modernization of aging diagnostic infrastructure. The Middle East is expanding advanced imaging capacity through tertiary care development, national cancer programs, and medical city projects, particularly where oncology, cardiology, and specialty care programs are being prioritized. Africa shows selective but important progress, with nuclear imaging concentrated in major urban and academic centers; broader adoption depends on workforce development, cyclotron or generator access, service support, stable radiotracer supply, and sustainable funding models.

Key Group Insights Shaping Nuclear Imaging Equipment Demand

ASEAN countries are strengthening nuclear imaging capabilities through hospital upgrades, oncology service expansion, and cross-border healthcare investment, though adoption varies by income level, specialist availability, reimbursement readiness, and radiotracer supply infrastructure. GCC countries are emphasizing advanced diagnostic imaging as part of broader healthcare transformation programs, with investments in tertiary hospitals, cancer centers, and high-acuity care pathways supporting PET/CT and SPECT/CT deployment. The European Union benefits from coordinated regulatory frameworks, cross-country research collaboration, and well-established nuclear medicine standards, creating a favorable environment for quality assurance, radiation safety, and clinical integration. BRICS countries represent a diverse adoption landscape: China and India are expanding capacity through healthcare modernization and oncology demand, Brazil and South Africa continue to build access through leading urban centers, and Russia maintains established nuclear medicine capabilities shaped by domestic healthcare priorities. G7 countries generally demonstrate mature equipment bases, advanced radiopharmaceutical use, established reimbursement processes, and strong integration of nuclear imaging into oncology, cardiology, and neurology pathways. NATO member states overlap significantly with advanced European and North American healthcare systems, where equipment resilience, secure supply chains, cybersecurity, and high-reliability hospital infrastructure are increasingly relevant to diagnostic continuity.

Key Country Insights for Nuclear Imaging Equipment Markets

The United States remains one of the most developed environments for nuclear imaging equipment, supported by extensive PET and SPECT utilization in oncology, cardiology, and neurology, as well as mature radiopharmacy, accreditation, and clinical infrastructure. Canada emphasizes quality-controlled imaging services within publicly funded healthcare settings, with procurement shaped by provincial planning, access equity, and equipment renewal needs. Mexico is expanding advanced imaging access in major metropolitan and private healthcare centers, while wider availability is influenced by reimbursement, trained personnel, and radiotracer distribution. Brazil has the largest healthcare system in Latin America and uses nuclear imaging across major hospital networks, although geographic disparities affect access beyond leading urban centers. The United Kingdom supports nuclear imaging through guideline-driven cancer, cardiac, and neurological care pathways, with attention to capacity, workforce, and equipment modernization. Germany benefits from a strong clinical and technical base for hybrid imaging, radiopharmaceutical use, and hospital-based nuclear medicine. France maintains established nuclear medicine services with emphasis on regulated radioprotection, oncology imaging, and specialist care delivery. Russia has long-standing nuclear medicine capabilities and continues to apply SPECT and PET across oncology and cardiology services, supported by national healthcare infrastructure priorities. Italy and Spain both show mature use of nuclear imaging in public and private hospital networks, with modernization focused on hybrid systems, efficient patient throughput, and compliance with radiation safety requirements. China is rapidly expanding molecular imaging capacity through hospital construction, oncology demand, domestic healthcare modernization, and wider clinical adoption of hybrid imaging. India is increasing access to PET/CT and SPECT/CT through cancer center development and private-sector diagnostic investment, while affordability, isotope logistics, and workforce training remain important. Japan has advanced imaging infrastructure and strong clinical adoption in oncology, neurology, and cardiology, supported by sophisticated hospital networks and aging-population health needs. Australia maintains high-quality nuclear medicine services across major cities, with access shaped by geography, specialist distribution, and public-private service models. South Korea demonstrates strong uptake of advanced diagnostic technologies, supported by high hospital digitization, oncology care demand, established nuclear medicine expertise, and robust tertiary care infrastructure.

Actionable Recommendations for Nuclear Imaging Equipment Leaders

Industry leaders should prioritize equipment strategies that align clinical performance with operational efficiency, including faster scan protocols, dose optimization, automated quality control, and high system uptime. Product portfolios should support hybrid imaging, theranostic workflows, quantitative analytics, and seamless integration with hospital IT systems. Commercial teams should adapt offerings to regional realities, including financing flexibility, service coverage, radiotracer access, training programs, and total cost of ownership requirements. Partnerships with hospitals, radiopharmacies, academic centers, and regulatory stakeholders can strengthen adoption by addressing workflow redesign, staff education, and compliance readiness. Leaders should also invest in AI validation, cybersecurity, interoperability, and lifecycle support, as buyers increasingly evaluate digital capability alongside hardware performance. In emerging markets, sustainable growth depends on workforce development, service reliability, practical deployment models, and support structures that can function in environments with uneven infrastructure.

Research Methodology for Nuclear Imaging Equipment Analysis

A rigorous research methodology for nuclear imaging equipment analysis should combine secondary and primary evidence from validated healthcare, regulatory, clinical, and industry sources. Secondary research should examine peer-reviewed nuclear medicine literature, clinical guidelines, hospital procurement trends, regulatory documentation, reimbursement policies, radiopharmaceutical supply considerations, radiation safety standards, and public health data on cancer, cardiovascular disease, and neurological disorders. Primary research should include structured interviews with nuclear medicine physicians, radiologists, cardiologists, oncologists, hospital administrators, radiopharmacists, medical physicists, procurement leaders, and service engineers. Findings should be triangulated across clinical adoption indicators, installed technology trends, policy environments, workflow requirements, equipment replacement patterns, and regional infrastructure conditions. The methodology should exclude unsupported assumptions and avoid reliance on unverified claims, with emphasis on data validation, source credibility, and consistency across geographies and end-use settings.

Conclusion: Nuclear Imaging Equipment as a Driver of Precision Care

Nuclear imaging equipment is positioned at the intersection of molecular diagnostics, personalized medicine, and digitally enabled healthcare delivery. The field is being reshaped by hybrid imaging, AI-supported workflows, theranostic applications, radiotracer innovation, and the need for efficient, lower-dose, high-confidence diagnostic pathways. Regional adoption remains uneven, with mature systems focused on modernization and workflow optimization, while emerging healthcare systems prioritize access expansion, infrastructure development, and specialist training. Industry success will depend on delivering clinically validated technology, reliable service ecosystems, interoperable software, and adaptable commercial models. As healthcare providers seek earlier detection, more accurate staging, therapy selection, and better treatment monitoring, nuclear imaging equipment will remain essential to advanced diagnostic and therapeutic decision-making.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Nuclear Imaging Equipment Market, by Product Type

  • 7.1. Introduction
  • 7.2. Single Photon Emission Computed Tomography
  • 7.3. Positron Emission Tomography
  • 7.4. Planar Scintigraphy Systems
  • 7.5. Nuclear Imaging Software & Workstations
  • 7.6. Accessories & Ancillary Equipment

8. Nuclear Imaging Equipment Market, by Modality

  • 8.1. Introduction
  • 8.2. Diagnostic Nuclear Imaging
  • 8.3. Therapeutic Nuclear Imaging

9. Nuclear Imaging Equipment Market, by Technology

  • 9.1. Introduction
  • 9.2. Analog Nuclear Imaging Systems
  • 9.3. Digital Nuclear Imaging Systems
  • 9.4. Hybrid Imaging Technology

10. Nuclear Imaging Equipment Market, by Detector Type

  • 10.1. Introduction
  • 10.2. Scintillation Detectors
  • 10.3. Semiconductor Detectors

11. Nuclear Imaging Equipment Market, by Application

  • 11.1. Introduction
  • 11.2. Cardiology
  • 11.3. Infectious Disease Diagnosis
  • 11.4. Neurology
  • 11.5. Oncology
  • 11.6. Orthopedics

12. Nuclear Imaging Equipment Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Nuclear Imaging Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Nuclear Imaging Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Absolute Imaging Inc.
  • 16.2. Advanced Accelerator Applications S.A. by Norvatis
  • 16.3. Agfa-Gevaert N.V
  • 16.4. Bayer AG
  • 16.5. Bozlu Holding A. S.
  • 16.6. Bracco Imaging S.p.A.
  • 16.7. Canon Medical Systems Corporation
  • 16.8. CMR Naviscan Corporation
  • 16.9. Cubresa Inc.
  • 16.10. DDD-Diagnostic A/S
  • 16.11. Digirad Corporation
  • 16.12. Edge Medical Solutions Private Limited
  • 16.13. GE HealthCare Technologies Inc.
  • 16.14. Koninklijke Philips N.V.
  • 16.15. Mediso Ltd.
  • 16.16. MR Solutions Ltd.
  • 16.17. Neusoft Medical Systems Co., Ltd.
  • 16.18. PerkinElmer Inc.
  • 16.19. Revvity Inc
  • 16.20. Rigaku Corporation
  • 16.21. Shimadzu Corporation
  • 16.22. Siemens AG
  • 16.23. Surgiceye GmbH
  • 16.24. United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PLANAR SCINTIGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PLANAR SCINTIGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PLANAR SCINTIGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEAR IMAGING SOFTWARE & WORKSTATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEAR IMAGING SOFTWARE & WORKSTATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEAR IMAGING SOFTWARE & WORKSTATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ACCESSORIES & ANCILLARY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ACCESSORIES & ANCILLARY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ACCESSORIES & ANCILLARY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIAGNOSTIC NUCLEAR IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIAGNOSTIC NUCLEAR IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIAGNOSTIC NUCLEAR IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL THERAPEUTIC NUCLEAR IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL THERAPEUTIC NUCLEAR IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL THERAPEUTIC NUCLEAR IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANALOG NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANALOG NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANALOG NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HYBRID IMAGING TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HYBRID IMAGING TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HYBRID IMAGING TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SCINTILLATION DETECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SCINTILLATION DETECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SCINTILLATION DETECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SEMICONDUCTOR DETECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SEMICONDUCTOR DETECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SEMICONDUCTOR DETECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ORTHOPEDICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ORTHOPEDICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ORTHOPEDICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. GCC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GCC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. GCC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 106. GCC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. GCC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. GCC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. G7 NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. G7 NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. G7 NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 124. G7 NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. G7 NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. G7 NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. NATO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. NATO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NATO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 130. NATO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. NATO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NATO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. CANADA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. CANADA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. CANADA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 143. CANADA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. CANADA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. CANADA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. MEXICO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. MEXICO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MEXICO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 149. MEXICO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. MEXICO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MEXICO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. BRAZIL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. BRAZIL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. BRAZIL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 155. BRAZIL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. BRAZIL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. BRAZIL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED KINGDOM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED KINGDOM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED KINGDOM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED KINGDOM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED KINGDOM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED KINGDOM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. GERMANY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. GERMANY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. GERMANY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 167. GERMANY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. GERMANY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GERMANY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. FRANCE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. FRANCE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. FRANCE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 173. FRANCE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. FRANCE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. FRANCE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. RUSSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. RUSSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. RUSSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 179. RUSSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. RUSSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. RUSSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. ITALY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. ITALY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ITALY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 185. ITALY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. ITALY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ITALY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. SPAIN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. SPAIN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. SPAIN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 191. SPAIN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. SPAIN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. SPAIN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. INDIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. INDIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. INDIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 203. INDIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. INDIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. INDIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. JAPAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. JAPAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. JAPAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 209. JAPAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. JAPAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. JAPAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. AUSTRALIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. AUSTRALIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. AUSTRALIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 215. AUSTRALIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. AUSTRALIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. AUSTRALIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. SOUTH KOREA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. SOUTH KOREA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. SOUTH KOREA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 221. SOUTH KOREA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. SOUTH KOREA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. SOUTH KOREA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 225. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025